ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Overview Fund Activity
Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

66 hedge funds and large institutions have $23.7M invested in Zynerba Pharmaceuticals, Inc in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
+7
Holders Change %
+11.86%
% of All Funds
1.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
20
Reduced
14
Closed
11
Calls
$1.29M
Puts
$3.96M
Net Calls
-$2.67M
Net Calls Change
+$599K

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$2.69M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.32M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$612K
4
UOC
4
UBS O'Connor
Illinois
$519K
5
BlackRock
5
BlackRock
New York
$2.44M

Top Sellers

1
MWNA
1
Marshall Wace North America
New York
$0
2
Millennium Management
2
Millennium Management
New York
$1.26M
3
BCM
3
BlueCrest Capital Management
Jersey
$132K
4
PP
4
Paloma Partners
Connecticut
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$121K
Name Holding Trade Value Shares
Change 		Shares
Change %
APA
76
American Portfolios Advisors
New York
– -$2.09K -215 Closed
1 2 3
4